Literature DB >> 25640801

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia.

Mohanarasan Ratanam1, You Siang Ngim2, Nurliza Khalidin3, Visvaraja Subrayan3.   

Abstract

Entities:  

Keywords:  B Cells; Waldenström macroglobulinaemia; plasma exchange; vascular endothelial growth factors; venous thrombosis

Mesh：

Substances：

Year:  2015        PMID： 25640801     DOI： 10.1111/bjh.13307

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study.

Authors:  Anette Tarp Hansen; Katalin Veres; Paolo Prandoni; Kasper Adelborg; Henrik Toft Sørensen
Journal:  Cancer Med       Date:  2018-09-27       Impact factor: 4.452

2.  What the Silent Retina Tells You: Serous Retinal Detachment in Waldenström's Macroglobulinemia.

Authors:  Karima Amaador; Roselie Diederen; Jeroen Coumou; Josephine Vos
Journal:  Hemasphere       Date:  2021-01-20

3.  Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report.

Authors:  Jun Li; Rui Zhang; Feng Gu; Zhe-Li Liu; Peng Sun
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

4.  Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only.

Authors:  Michal Blau-Most; Raz Gepstein; Alexander Rubowitz
Journal:  Am J Ophthalmol Case Rep       Date:  2018-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.